fujiwara shinichirou

FacultyInternalMedicineHematology
Job titleAssistant ProfessorWeb site

Profile

Research Keywords

    RCAN1, CD25

Research Areas

  • Clinical internal medicine / Hematology
  • Boundary medicine / Laboratory medicine

Research Activities

Papers(paper)

  • Clinical features of de novo CD25-positive follicular lymphoma.
    Fujiwara S, Muroi K, Tatara R, Matsuyama T, Ohmine K, Suzuki T, Mori M, Nagai T, Tanaka A, Ozawa K
    Leukemia & lymphoma 55 307-313 Feb. 2014
  • Intrathecal administration of high-titer cytomegalovirus immunoglobulin for cytomegalovirus meningitis.
    Fujiwara S, Muroi K, Tatara R, Ohmine K, Matsuyama T, Mori M, Nagai T, Ozawa K
    Case reports in hematology 2014 272458 2014
  • STK10 missense mutations associated with anti-apoptotic function.
    Fukumura K, Yamashita Y, Kawazu M, Sai E, Fujiwara S, Nakamura N, Takeuchi K, Ando M, Miyazono K, Ueno T, Ozawa K, Mano H
    Oncology reports 30 1542-1548 Oct. 2013
  • Clinical features of de novo CD25(+) diffuse large B-cell lymphoma.
    Fujiwara S, Muroi K, Hirata Y, Sato K, Matsuyama T, Ohmine K, Suzuki T, Ozaki K, Mori M, Nagai T, Tanaka A, Ozawa K
    Hematology (Amsterdam, Netherlands) 18 14-19 Jan. 2013
  • Sepsis and meningoencephalitis caused by Bacillus cereus in a patient with myelodysplastic syndrome.
    Tatara R, Nagai T, Suzuki M, Oh I, Fujiwara S, Norizuki M, Muroi K, Ozawa K
    Internal medicine (Tokyo, Japan) 52 1987-1990 2013
  • CD56 expression in normal immature granulocytes after allogeneic hematopoietic stem cell transplantation.
    Muroi K, Fujiwara S, Tatara R, Sugimoto M, Yamamoto C, Uehara E, Meguro A, Hatano K, Okazuka K, Oh I, Ohmine K, Suzuki T, Mori M, Nagai T, Ozawa K
    Journal of clinical and experimental hematopathology : JCEH 53 247-250 2013
  • [Usefulness of a slow-release tacrolimus for a patient with tacrolimus-induced renal injury after hemopoietic stem cell transplantation].
    Hosonuma R, Fujiwara S, Sasazaki M, Hirata Y, Yamamoto C, Uesawa M, Oh I, Matsuyama T, Mori M, Ozawa K, Muroi K
    [Rinsho ketsueki] The Japanese journal of clinical hematology 53 469-471 Apr. 2012
  • Rituximab plus 70% cyclophosphamide, doxorubicin, vincristine and prednisone for Japanese patients with diffuse large B-cell lymphoma aged 70 years and older.
    Meguro A, Ozaki K, Sato K, Oh I, Fujiwara S, Hosonuma R, Sasazaki M, Kikuchi Y, Hirata Y, Yamamoto C, Uesawa M, Kobayashi H, Matsu H, Okabe H, Uehara E, Nishikawa A, Tatara R, Hatano K, Yamamoto C, Matsuyama T, Toshima M, Ueda M, Ohmine K, Suzuki T, Mori M, Nagai T, Muroi K, Ozawa K
    Leukemia & lymphoma 53 43-49 Jan. 2012
  • Prediction of progression from refractory cytopenia with unilineage dysplasia by analysis of bone marrow blast cell composition.
    Oka S, Muroi K, Fujiwara S, Oh I, Matsuyama T, Ohmine K, Suzuki T, Ozaki K, Mori M, Nagai T, Ozawa K, Hanafusa T
    Journal of clinical and experimental hematopathology : JCEH 52 63-66 2012
  • Autologous hematopoietic recovery with aberrant antigen expression after allogeneic bone marrow transplantation.
    Kobayashi H, Matsuyama T, Oka S, Fujiwara S, Oh I, Suzuki T, Ozaki K, Mori M, Nagai T, Ozawa K, Muroi K
    Journal of clinical and experimental hematopathology : JCEH 52 81-83 2012
Display all
Papers(paper)close
  • Clinical features of de novo CD25-positive follicular lymphoma.
    Fujiwara S, Muroi K, Tatara R, Matsuyama T, Ohmine K, Suzuki T, Mori M, Nagai T, Tanaka A, Ozawa K
    Leukemia & lymphoma 55 307-313 Feb. 2014
  • Intrathecal administration of high-titer cytomegalovirus immunoglobulin for cytomegalovirus meningitis.
    Fujiwara S, Muroi K, Tatara R, Ohmine K, Matsuyama T, Mori M, Nagai T, Ozawa K
    Case reports in hematology 2014 272458 2014
  • STK10 missense mutations associated with anti-apoptotic function.
    Fukumura K, Yamashita Y, Kawazu M, Sai E, Fujiwara S, Nakamura N, Takeuchi K, Ando M, Miyazono K, Ueno T, Ozawa K, Mano H
    Oncology reports 30 1542-1548 Oct. 2013
  • Clinical features of de novo CD25(+) diffuse large B-cell lymphoma.
    Fujiwara S, Muroi K, Hirata Y, Sato K, Matsuyama T, Ohmine K, Suzuki T, Ozaki K, Mori M, Nagai T, Tanaka A, Ozawa K
    Hematology (Amsterdam, Netherlands) 18 14-19 Jan. 2013
  • Sepsis and meningoencephalitis caused by Bacillus cereus in a patient with myelodysplastic syndrome.
    Tatara R, Nagai T, Suzuki M, Oh I, Fujiwara S, Norizuki M, Muroi K, Ozawa K
    Internal medicine (Tokyo, Japan) 52 1987-1990 2013
  • CD56 expression in normal immature granulocytes after allogeneic hematopoietic stem cell transplantation.
    Muroi K, Fujiwara S, Tatara R, Sugimoto M, Yamamoto C, Uehara E, Meguro A, Hatano K, Okazuka K, Oh I, Ohmine K, Suzuki T, Mori M, Nagai T, Ozawa K
    Journal of clinical and experimental hematopathology : JCEH 53 247-250 2013
  • [Usefulness of a slow-release tacrolimus for a patient with tacrolimus-induced renal injury after hemopoietic stem cell transplantation].
    Hosonuma R, Fujiwara S, Sasazaki M, Hirata Y, Yamamoto C, Uesawa M, Oh I, Matsuyama T, Mori M, Ozawa K, Muroi K
    [Rinsho ketsueki] The Japanese journal of clinical hematology 53 469-471 Apr. 2012
  • Rituximab plus 70% cyclophosphamide, doxorubicin, vincristine and prednisone for Japanese patients with diffuse large B-cell lymphoma aged 70 years and older.
    Meguro A, Ozaki K, Sato K, Oh I, Fujiwara S, Hosonuma R, Sasazaki M, Kikuchi Y, Hirata Y, Yamamoto C, Uesawa M, Kobayashi H, Matsu H, Okabe H, Uehara E, Nishikawa A, Tatara R, Hatano K, Yamamoto C, Matsuyama T, Toshima M, Ueda M, Ohmine K, Suzuki T, Mori M, Nagai T, Muroi K, Ozawa K
    Leukemia & lymphoma 53 43-49 Jan. 2012
  • Prediction of progression from refractory cytopenia with unilineage dysplasia by analysis of bone marrow blast cell composition.
    Oka S, Muroi K, Fujiwara S, Oh I, Matsuyama T, Ohmine K, Suzuki T, Ozaki K, Mori M, Nagai T, Ozawa K, Hanafusa T
    Journal of clinical and experimental hematopathology : JCEH 52 63-66 2012
  • Autologous hematopoietic recovery with aberrant antigen expression after allogeneic bone marrow transplantation.
    Kobayashi H, Matsuyama T, Oka S, Fujiwara S, Oh I, Suzuki T, Ozaki K, Mori M, Nagai T, Ozawa K, Muroi K
    Journal of clinical and experimental hematopathology : JCEH 52 81-83 2012
  • Flow cytometric analysis of kappa and lambda light chain expression in endoscopic biopsy specimens before the diagnosis of B-cell lymphoma.
    Oka S, Muroi K, Sato K, Fujiwara S, Oh I, Matsuyama T, Ohmine K, Suzuki T, Ozaki K, Mori M, Nagai T, Fukushima N, Fukushima N, Tanaka A, Ozawa K
    Journal of clinical and experimental hematopathology : JCEH 52 127-131 2012
  • Use of cryoprotectant-depleted allogeneic peripheral blood stem cells for transplantation.
    Hirata Y, Kishino K, Onozaki F, Nakaki Y, Fujiwara S, Yamamoto C, Sato K, Matsuyama T, Ozaki K, Mori M, Ozawa K, Muroi K
    Hematology (Amsterdam, Netherlands) 16 221-224 Jul. 2011
  • Incidental carcinomas detected by PET/CT scans in patients with malignant lymphoma.
    Sato K, Ozaki K, Fujiwara S, Oh I, Matsuyama T, Ohmine K, Suzuki T, Mori M, Nagai T, Muroi K, Ozawa K
    International journal of hematology 92 647-650 Nov. 2010
  • Combination of tipifarnib and rapamycin synergistically inhibits the growth of leukemia cells and overcomes resistance to tipifarnib via alteration of cellular signaling pathways.
    Nagai T, Ohmine K, Fujiwara S, Uesawa M, Sakurai C, Ozawa K
    Leukemia research 34 1057-1063 Aug. 2010
  • Screening for genetic abnormalities involved in ovarian carcinogenesis using retroviral expression libraries.
    Wada T, Yamashita Y, Saga Y, Takahashi K, Koinuma K, Choi YL, Kaneda R, Fujiwara S, Soda M, Watanabe H, Kurashina K, Hatanaka H, Enomoto M, Takada S, Mano H, Suzuki M
    International journal of oncology 35 973-976 Nov. 2009
  • Prediction of response to imatinib in patients with chronic myelogenous leukemia by flow cytometric analysis of bone marrow blastic cell phenotypes.
    Oka S, Muroi K, Mori M, Matsuyama T, Fujiwara S, Oh I, Sato K, Kikuchi S, Ueda M, Toshima M, Suzuki T, Ozaki K, Nagai T, Ozawa K
    Leukemia & lymphoma 50 290-293 Feb. 2009
  • Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer.
    Soda M, Choi YL, Enomoto M, Takada S, Yamashita Y, Ishikawa S, Fujiwara S, Watanabe H, Kurashina K, Hatanaka H, Bando M, Ohno S, Ishikawa Y, Aburatani H, Niki T, Sohara Y, Sugiyama Y, Mano H
    Nature 448 561-566 Aug. 2007
  • [Benefits of mycophenolate mofetil for refractory graft-versus-host disease].
    Mori M, Muroi K, Matsuyama T, Oka S, Ono Y, Yamamoto C, Uesawa M, Okabe H, Matsu H, Tatara R, Kikuchi Y, Fujiwara S, Kikuchi S, Sato K, Ueda M, Toshima M, Ozaki K, Takatoku M, Nagai T, Ozawa K
    [Rinsho ketsueki] The Japanese journal of clinical hematology 48 624-631 Aug. 2007
  • Transforming activity of purinergic receptor P2Y, G-protein coupled, 2 revealed by retroviral expression screening.
    Hatanaka H, Takada S, Choi YL, Fujiwara S, Soda M, Enomoto M, Kurashina K, Watanabe H, Yamashita Y, Sugano K, Mano H
    Biochemical and biophysical research communications 356 723-726 May 2007
  • Transforming activity of purinergic receptor P2Y, G protein coupled, 8 revealed by retroviral expression screening.
    Fujiwara S, Yamashita Y, Choi YL, Watanabe H, Kurashina K, Soda M, Enomoto M, Hatanaka H, Takada S, Ozawa K, Mano H
    Leukemia & lymphoma 48 978-986 May 2007
  • Development of streptococcus meningitis and Epstein-Barr virus reactivation after non-T-cell-depleted human leukocyte antigen-haploidentical peripheral blood stem cell transplantation based on feto-maternal microchimerism.
    Fujiwara S, Muroi K, Kikuchi S, Kawano-Yamamoto C, Matsuyama T, Mori M, Nagai T, Akutsu M, Ozawa K
    Leukemia & lymphoma 48 640-642 Mar. 2007
  • Identification of a constitutively active mutant of JAK3 by retroviral expression screening.
    Choi YL, Kaneda R, Wada T, Fujiwara S, Soda M, Watanabe H, Kurashina K, Hatanaka H, Enomoto M, Takada S, Yamashita Y, Mano H
    Leukemia research 31 203-209 Feb. 2007
  • Pleocytosis after hemopoietic stem cell transplantation.
    Nagashima T, Muroi K, Kawano-Yamamoto C, Miyoshi T, Tatara R, Meguro A, Fujiwara S, Obara Y, Oh I, Kikuchi S, Sato K, Matsuyama T, Toshima M, Ohmine K, Ozaki K, Takatoku M, Mori M, Nagai T, Ozawa K
    Leukemia & lymphoma 47 1613-1617 Aug. 2006
  • Nucleotide sequence and embryonic expression of quail and duck Sox9 genes.
    Takada S, Ota J, Kansaku N, Yamashita H, Izumi T, Ishikawa M, Wada T, Kaneda R, Choi YL, Koinuma K, Fujiwara S, Aoki H, Kisanuki H, Yamashita Y, Mano H
    General and comparative endocrinology 145 208-213 Jan. 2006
  • Mouse microRNA profiles determined with a new and sensitive cloning method.
    Takada S, Berezikov E, Yamashita Y, Lagos-Quintana M, Kloosterman WP, Enomoto M, Hatanaka H, Fujiwara S, Watanabe H, Soda M, Choi YL, Plasterk RH, Cuppen E, Mano H
    Nucleic acids research 34 e115 2006
  • Transforming activity of the lymphotoxin-beta receptor revealed by expression screening.
    Fujiwara S, Yamashita Y, Choi YL, Wada T, Kaneda R, Takada S, Maruyama Y, Ozawa K, Mano H
    Biochemical and biophysical research communications 338 1256-1262 Dec. 2005
  • Retroviral expression screening of oncogenes in pancreatic ductal carcinoma.
    Kisanuki H, Choi YL, Wada T, Moriuchi R, Fujiwara S, Kaneda R, Koinuma K, Ishikawa M, Takada S, Yamashita Y, Mano H
    European journal of cancer (Oxford, England : 1990) 41 2170-2175 Sep. 2005
  • DNA microarray analysis of dysplastic morphology associated with acute myeloid leukemia.
    Tsutsumi C, Ueda M, Miyazaki Y, Yamashita Y, Choi YL, Ota J, Kaneda R, Koinuma K, Fujiwara S, Kisanuki H, Ishikawa M, Ozawa K, Tomonaga M, Mano H
    Experimental hematology 32 828-835 Sep. 2004
  • Proteomic analysis of hematopoietic stem cell-like fractions in leukemic disorders.
    Ota J, Yamashita Y, Okawa K, Kisanuki H, Fujiwara S, Ishikawa M, Lim Choi Y, Ueno S, Ohki R, Koinuma K, Wada T, Compton D, Kadoya T, Mano H
    Oncogene 22 5720-5728 Aug. 2003
  • CD25 as an adverse prognostic factor in elderly patients with acute myeloid leukemia.
    Fujiwara SI, Muroi K, Yamamoto C, Hatano K, Okazuka K, Sato K, Oh I, Ohmine K, Suzuki T, Ozawa K
    Hematology (Amsterdam, Netherlands) 22(6) 347-353 Jul. 2017
  • Development of acute myeloid leukemia in patients with untreated chronic lymphocytic leukemia.
    Ito S, Fujiwara SI, Mashima K, Umino K, Minakata D, Nakano H, Yamasaki R, Kawasaki Y, Sugimoto M, Ashizawa M, Yamamoto C, Hatano K, Okazuka K, Sato K, Oh I, Ohmine K, Suzuki T, Muroi K, Kanda Y
    Annals of hematology 96(5) 719-724 May 2017
  • Relationship between white blood cell count elevation and clinical response after G-CSF priming chemotherapy for acute myeloid leukemia.
    Minakata D, Fujiwara SI, Ikeda T, Toda Y, Ito S, Mashima K, Umino K, Nakano H, Yamasaki R, Morita K, Kawasaki Y, Sugimoto M, Yamamoto C, Ashizawa M, Hatano K, Sato K, Oh I, Ohmine K, Muroi K, Kanda Y
    International journal of hematology May 2017
  • Prognostic value of the soluble interleukin-2 receptor level after patients with follicular lymphoma achieve a response to R-CHOP.
    Umino K, Fujiwara SI, Ikeda T, Toda Y, Ito S, Mashima K, Minakata D, Nakano H, Yamasaki R, Kawasaki Y, Sugimoto M, Yamamoto C, Ashizawa M, Hatano K, Sato K, Oh I, Ohmine K, Muroi K, Kanda Y
    Hematology (Amsterdam, Netherlands) 1-6 Apr. 2017
  • Serum soluble interleukin-2 receptor level at diagnosis predicts transformation in patients with follicular lymphoma.
    Umino K, Fujiwara SI, Ito S, Mashima K, Minakata D, Nakano H, Yamasaki R, Kawasaki Y, Sugimoto M, Ashizawa M, Hatano K, Okazuka K, Sato K, Oh I, Ohmine K, Suzuki T, Muroi K, Kanda Y
    Leukemia & lymphoma 58(2) 316-323 Feb. 2017
  • High-Dose Methotrexate and Cytarabine-Based Multi-Agent Chemotherapy (Modified Bonn Protocol) for Systemic Lymphoma with CNS Involvement.
    Umino K, Fujiwara SI, Sato K, Minakata D, Nakano H, Yamasaki R, Kawasaki Y, Sugimoto M, Yamamoto C, Hatano K, Okazuka K, Oh I, Ohmine K, Suzuki T, Muroi K, Kanda Y
    Acta haematologica 137(2) 93-99 2017
  • Dose-reduced combination of mitoxantrone, etoposide, and cytarabine (miniMEC) for relapsed and refractory acute leukemia.
    Yamamoto C, Ito S, Mashima K, Umino K, Minakata D, Yamasaki R, Kawasaki Y, Sugimoto M, Nakano H, Ashizawa M, Okazuka K, Hatano K, Sato K, Oh I, Fujiwara S, Ohmine K, Suzuki T, Muroi K, Kanda Y
    Leukemia & lymphoma 57(11) 2541-2547 Nov. 2016
  • Prospective randomized and crossover comparison of two apheresis machines for peripheral blood stem cell collection: a multicenter study.
    Ikeda K, Minakawa K, Muroi K, Fujiwara SI, Yamada-Fujiwara M, Fujimori Y, Tanosaki R, Ohto H, Study Group for Peripheral Blood Stem Cell Collection,Cell Therapy Committee,The Japan Society of Transfusion Medicine and Cell Therapy.
    Transfusion 56(11) 2839-2847 Nov. 2016
  • Efficacy of combination therapy with anti-thymocyte globulin and cyclosporine A as a first-line treatment in adult patients with aplastic anemia: a comparison of rabbit and horse formulations.
    Suzuki T, Kobayashi H, Kawasaki Y, Okazuka K, Hatano K, Fujiwara S, Oh I, Ohmine K, Kanda Y
    International journal of hematology 104(4) 446-453 Oct. 2016
  • An Open-labeled, Multicenter Phase II Study of Tamibarotene in Patients with Steroid-refractory Chronic Graft-versus-Host Disease.
    Maeda Y, Nishimori H, Inamoto Y, Nakamae H, Sawa M, Mori Y, Ohashi K, Fujiwara SI, Tanimoto M
    Acta medica Okayama 70(5) 409-412 Oct. 2016
  • Retrospective evaluation of the MEAM regimen as a conditioning regimen before autologous peripheral blood stem cell transplantation for lymphoma in two centers with different dosing schedules of melphalan.
    Sugimoto M, Ito S, Mashima K, Umino K, Minakata D, Nakano H, Yamasaki R, Kawasaki Y, Ashizawa M, Yamamoto C, Fujiwara S, Okazuka K, Hatano K, Sato K, Oh I, Ohmine K, Suzuki T, Muroi K, Kako S, Kanda Y
    Annals of hematology 95(9) 1513-1519 Sep. 2016
  • A low-dose cytarabine, aclarubicin and granulocyte colony-stimulating factor priming regimen versus a daunorubicin plus cytarabine regimen as induction therapy for older patients with acute myeloid leukemia: A propensity score analysis.
    Minakata D, Fujiwara S, Ito S, Mashima K, Umino K, Nakano H, Kawasaki Y, Sugimoto M, Yamasaki R, Yamamoto C, Ashizawa M, Hatano K, Okazuka K, Sato K, Oh I, Ohmine K, Suzuki T, Muroi K, Kanda Y
    Leukemia research 42 82-87 Mar. 2016
  • The prognostic significance of rapid peripheral blood blast clearance during the initial course of induction chemotherapy in young patients with de novo acute myeloid leukemia.
    Nakano H, Fujiwara SI, Ito S, Mashima K, Umino K, Minakata D, Yamasaki R, Kawasaki Y, Sugimoto M, Ashizawa M, Yamamoto C, Hatano K, Okazuka K, Sato K, Oh I, Ohmine K, Suzuki T, Muroi K, Kanda Y
    Hematological oncology Dec. 2015
  • Distribution of serum erythropoietin levels in Japanese patients with myelodysplastic syndromes.
    Suzuki T, Oh I, Ohmine K, Meguro A, Mori M, Fujiwara S, Yamamoto C, Nagai T, Ozawa K
    International journal of hematology 101(1) 32-36 Jan. 2015
  • Leukemia cells directly phagocytose blood cells in AML-associated hemophagocytic lymphohistiocytosis: a case report and review of the literature.
    Hatano K, Nagai T, Matsuyama T, Sakaguchi Y, Fujiwara S, Oh I, Muroi K, Ozawa K
    Acta haematologica 133(1) 98-100 2015
  • Hemoperfusion for Hodgkin lymphoma-associated hemophagocytic lymphohistiocytosis.
    Tatara R, Sato M, Fujiwara S, Oh I, Muroi K, Ozawa K, Nagai T
    Internal medicine (Tokyo, Japan) 53(20) 2365-2368 2014
  • Two granulocytic regions in bone marrow with eosinophilia evaluated by flow cytometry.
    Muroi K, Fujiwara S, Tatara R, Sato K, Oh I, Ohmine K, Suzuki T, Nagai T, Ozawa K, Kanda Y
    Journal of clinical and experimental hematopathology : JCEH 54(3) 243-245 2014

Papers(other)

  • ISOLATION OF MONONUCLEAR CELLS FROM BONE MARROW BLOOD FOR BONE MARROW TRANSPLANTATION USING SEPAX^
    KISHINO Koji, NAKAKI Yoko, ONOZAKI Fumiko, SHINDOU Seiko, OTSUKI Ikuko, KOBAYASHI Mika, OBATA Takashi, TAMURA Mistuko, SUGANO Naoko, FUJIWARA Shin-ichiro, MATSUYAMA Tomohiro, MORI Masaki, OZAWA Keiya, MUROI Kazuo
    58(3) 456-462 Jun. 2012
  • Usefulness of a slow-release tacrolimus for a patient with tacrolimus-induced renal injury after hemopoietic stem cell transplantation
    HOSONUMA Rie, FUJIWARA Shin-ichiro, SASAZAKI Miyuki, HIRATA Yuji, YAMAMOTO Chihiro, UESAWA Mitsuyo, OH Iekuni, MATSUYAMA Tomohiro, MORI Masaki, OZAWA Keiya, MUROI Kazuo
    53(4) 469-471 Apr. 2012
  • A Pilot Study of A Novel Therapy Using Mesenchymal Stromal Cells for Steroid-Resistant Graft-Versus-Host Disease
    Kazuya Sato, Kazuo Muroi, Satoko Oka, Miyuki Sasazaki, Rie Hosonuma, Katsutoshi Ozaki, Shin-ichiro Fujiwara, Iekuni Oh, Tomohiro Matsuyama, Ken Ohmine, Takahiro Suzuki, Masaki Mori, Tadashi Nagai, Keiya Ozawa
    Jichi Medical University journal 34 149-157 Mar. 2012
  • USE OF A STANDARD CENTRAL VENOUS CATHETER FOR AUTOLOGOUS PERIPHERAL BLOOD STEM CELL COLLECTION
    FUJIWARA Shin-ichiro, SATO Kazuya, HIRATA Yuji, YAMAMOTO Chizuru, MATSUYAMA Tomohiro, OZAKI Katsutoshi, MORI Masaki, YAGINUMA Kaori, SUGANO Naoko, NAKAKI Yoko, KISHINO Koji, OZAWA Keiya, MUROI Kazuo
    57(4) 283-288 Aug. 2011
  • Improved outcome of Burkitt lymphoma/leukemia treated with a new strategy
    Miyuki Sasazaki, Masaki Mori, Mituyo Uesawa, Shinitirou Fuziwara, Yuuzi Kikuti, Kazuya Satou, Tomohiro Matuyama, Ken Oomine, Masuzu Ueda, Takahiro Suzuki, Katutosi Ozaki, Tadashi Nagai, Kazuo Muroi, Keiya Ozawa
    Jichi Medical University journal 33 23-28 Mar. 2011
  • Flow cytometry to detect minimal residual disease after bone marrow transplantation in a patient with acute myeloblastic leukemia
    Satoko Oka, Kazuo Muroi, Masaki Mori, Tomohiro Matsuyama, Shin-ichiro Fujiwara, Iekuni Oh, Kazuya Sato, Masuzu Ueda, Takahiro Suzuki, Katsutoshi Ozaki, Tadashi Nagai, Keiya Ozawa
    Jichi Medical University journal 33 167-174 Mar. 2011
  • EVALUATION OF PLATELET TRANSFUSION THRESHOLD IN PATIENTS WITH ACUTE LEUKEMIA RECEIVING INDUCTION CHEMOTHERAPY
    OKA Satoko, MATSUYAMA Tomohiro, MORI Masaki, FUJIWARA Shin-ichiro, OHO Iekuni, KIKUCHI Satoru, SATO Kazuya, UEDA Masuzu, TOSHIMA Masaki, SUZUKI Takahiro, OZAKI Katsutoshi, NAGAI Tadashi, OZAWA Keiya, MUROI Kazuo
    55(5) 589-595 Nov. 2009
  • CYTOMEGALOVIRUS RETINITIS IN AN ADULT T-CELL LEUKEMIA PATIENT AFTER
    Tatara Raine, Mori Masaki, Fujiwara Shin-ichiro, Miyoshi Takuji, Sato Kazuya, Yamamoto Chizuru, Matsuyama Tomohiro, Toshima Masaki, Ohmine Ken, Ozaki Katsutoshi, Takatoku Masaaki, Nagai Tadashi, Ozawa Keiya, Muroi Kazuo
    Jichi Medical University journal 30 81-87 Dec. 2007
  • Benefits of mycophenolate mofetil for refractory graft-versus-host disease
    MORI Masaki, MUROI Kazuo, MATSUYAMA Tomohiro, OKA Satoko, ONO Yoko, YAMAMOTO Chizuru, UESAWA Mitsuyo, OKABE Hiroshi, MATSU Haruko, TATARA Raine, KIKUCHI Yuji, FUJIWARA Shinichiro, KIKUCHI Satoru, SATO Kazuya, UEDA Masuzu, TOSHIMA Masaki, OZAKI Katsutoshi, TAKATOKU Masaaki, NAGAI Tadashi, OZAWA Keiya
    48(8) 624-631 Aug. 2007
Display all
Papers(other)close
  • ISOLATION OF MONONUCLEAR CELLS FROM BONE MARROW BLOOD FOR BONE MARROW TRANSPLANTATION USING SEPAX^
    KISHINO Koji, NAKAKI Yoko, ONOZAKI Fumiko, SHINDOU Seiko, OTSUKI Ikuko, KOBAYASHI Mika, OBATA Takashi, TAMURA Mistuko, SUGANO Naoko, FUJIWARA Shin-ichiro, MATSUYAMA Tomohiro, MORI Masaki, OZAWA Keiya, MUROI Kazuo
    58(3) 456-462 Jun. 2012
  • Usefulness of a slow-release tacrolimus for a patient with tacrolimus-induced renal injury after hemopoietic stem cell transplantation
    HOSONUMA Rie, FUJIWARA Shin-ichiro, SASAZAKI Miyuki, HIRATA Yuji, YAMAMOTO Chihiro, UESAWA Mitsuyo, OH Iekuni, MATSUYAMA Tomohiro, MORI Masaki, OZAWA Keiya, MUROI Kazuo
    53(4) 469-471 Apr. 2012
  • A Pilot Study of A Novel Therapy Using Mesenchymal Stromal Cells for Steroid-Resistant Graft-Versus-Host Disease
    Kazuya Sato, Kazuo Muroi, Satoko Oka, Miyuki Sasazaki, Rie Hosonuma, Katsutoshi Ozaki, Shin-ichiro Fujiwara, Iekuni Oh, Tomohiro Matsuyama, Ken Ohmine, Takahiro Suzuki, Masaki Mori, Tadashi Nagai, Keiya Ozawa
    Jichi Medical University journal 34 149-157 Mar. 2012
  • USE OF A STANDARD CENTRAL VENOUS CATHETER FOR AUTOLOGOUS PERIPHERAL BLOOD STEM CELL COLLECTION
    FUJIWARA Shin-ichiro, SATO Kazuya, HIRATA Yuji, YAMAMOTO Chizuru, MATSUYAMA Tomohiro, OZAKI Katsutoshi, MORI Masaki, YAGINUMA Kaori, SUGANO Naoko, NAKAKI Yoko, KISHINO Koji, OZAWA Keiya, MUROI Kazuo
    57(4) 283-288 Aug. 2011
  • Improved outcome of Burkitt lymphoma/leukemia treated with a new strategy
    Miyuki Sasazaki, Masaki Mori, Mituyo Uesawa, Shinitirou Fuziwara, Yuuzi Kikuti, Kazuya Satou, Tomohiro Matuyama, Ken Oomine, Masuzu Ueda, Takahiro Suzuki, Katutosi Ozaki, Tadashi Nagai, Kazuo Muroi, Keiya Ozawa
    Jichi Medical University journal 33 23-28 Mar. 2011
  • Flow cytometry to detect minimal residual disease after bone marrow transplantation in a patient with acute myeloblastic leukemia
    Satoko Oka, Kazuo Muroi, Masaki Mori, Tomohiro Matsuyama, Shin-ichiro Fujiwara, Iekuni Oh, Kazuya Sato, Masuzu Ueda, Takahiro Suzuki, Katsutoshi Ozaki, Tadashi Nagai, Keiya Ozawa
    Jichi Medical University journal 33 167-174 Mar. 2011
  • EVALUATION OF PLATELET TRANSFUSION THRESHOLD IN PATIENTS WITH ACUTE LEUKEMIA RECEIVING INDUCTION CHEMOTHERAPY
    OKA Satoko, MATSUYAMA Tomohiro, MORI Masaki, FUJIWARA Shin-ichiro, OHO Iekuni, KIKUCHI Satoru, SATO Kazuya, UEDA Masuzu, TOSHIMA Masaki, SUZUKI Takahiro, OZAKI Katsutoshi, NAGAI Tadashi, OZAWA Keiya, MUROI Kazuo
    55(5) 589-595 Nov. 2009
  • CYTOMEGALOVIRUS RETINITIS IN AN ADULT T-CELL LEUKEMIA PATIENT AFTER
    Tatara Raine, Mori Masaki, Fujiwara Shin-ichiro, Miyoshi Takuji, Sato Kazuya, Yamamoto Chizuru, Matsuyama Tomohiro, Toshima Masaki, Ohmine Ken, Ozaki Katsutoshi, Takatoku Masaaki, Nagai Tadashi, Ozawa Keiya, Muroi Kazuo
    Jichi Medical University journal 30 81-87 Dec. 2007
  • Benefits of mycophenolate mofetil for refractory graft-versus-host disease
    MORI Masaki, MUROI Kazuo, MATSUYAMA Tomohiro, OKA Satoko, ONO Yoko, YAMAMOTO Chizuru, UESAWA Mitsuyo, OKABE Hiroshi, MATSU Haruko, TATARA Raine, KIKUCHI Yuji, FUJIWARA Shinichiro, KIKUCHI Satoru, SATO Kazuya, UEDA Masuzu, TOSHIMA Masaki, OZAKI Katsutoshi, TAKATOKU Masaaki, NAGAI Tadashi, OZAWA Keiya
    48(8) 624-631 Aug. 2007


Copyright c MEDIA FUSION Co.,Ltd. All rights reserved.